Comparing full cascade to IUD-only intervention
Problem
Component analysis allows us to run individual treatments (NSAID, TXA, Pill, hIUD) standalone and compare their impacts. However, comparing the full cascade to an IUD-only scenario may not be appropriate if we use the same uptake parameters.
In the full cascade:
- Women progress through multiple treatment options (NSAID → TXA → Pill → hIUD)
- Only a subset reaches hIUD after trying earlier treatments
- hIUD uptake depends on cascade position and prior treatment failures
In an IUD-only scenario:
- hIUD is offered as first-line treatment
- No prerequisite treatments required
- Potentially different care-seeking patterns
- Different acceptance rates when offered as first vs last option
Questions
-
Uptake rates: Should IUD-only intervention use the same acceptance probability as when hIUD is offered in the cascade, or should we model different acceptance for first-line vs last-resort treatment?
-
Care-seeking: Do women seek care differently when hIUD is the only option vs when multiple treatment options exist?
-
Fertility intent filtering: In the cascade, women with fertility intent never reach hIUD (blocked by Pill requirement). In IUD-only, should we apply the same fertility intent filter, or would different counseling/messaging affect this?
-
Population coverage: The cascade naturally selects for women who failed earlier treatments. IUD-only would reach a different population. How do we account for this in impact comparisons?
Discussion
Need to determine whether component analysis should adjust uptake parameters for realistic scenario comparisons or maintain identical parameters to isolate treatment efficacy effects.
Comparing full cascade to IUD-only intervention
Problem
Component analysis allows us to run individual treatments (NSAID, TXA, Pill, hIUD) standalone and compare their impacts. However, comparing the full cascade to an IUD-only scenario may not be appropriate if we use the same uptake parameters.
In the full cascade:
In an IUD-only scenario:
Questions
Uptake rates: Should IUD-only intervention use the same acceptance probability as when hIUD is offered in the cascade, or should we model different acceptance for first-line vs last-resort treatment?
Care-seeking: Do women seek care differently when hIUD is the only option vs when multiple treatment options exist?
Fertility intent filtering: In the cascade, women with fertility intent never reach hIUD (blocked by Pill requirement). In IUD-only, should we apply the same fertility intent filter, or would different counseling/messaging affect this?
Population coverage: The cascade naturally selects for women who failed earlier treatments. IUD-only would reach a different population. How do we account for this in impact comparisons?
Discussion
Need to determine whether component analysis should adjust uptake parameters for realistic scenario comparisons or maintain identical parameters to isolate treatment efficacy effects.